SPDR SERIES TRUST - S&P BIOTECH (XBI)

CUSIP: 78464A870

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / S&P BIOTECH
Total 13F shares
9,380,554
Share change
-9,005
Total reported value
$1,221,448,239
Put/Call ratio
17%
Price per share
$130.20
Number of holders
122
Value change
-$1,172,245
Number of buys
5
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 78464A870?
CUSIP 78464A870 identifies XBI - SPDR SERIES TRUST - S&P BIOTECH in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q4 2013

As of 31 Dec 2013, SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by 122 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,380,554 shares. The largest 10 holders included JPMORGAN CHASE & CO, GOLDMAN SACHS GROUP INC, MORGAN STANLEY, CITIGROUP INC, WELLS FARGO & COMPANY/MN, BARCLAYS PLC, BANK OF AMERICA CORP /DE/, Mirae Asset Global Investments Co., Ltd., STATE OF WISCONSIN INVESTMENT BOARD, and DEUTSCHE BANK AG\. This page lists 122 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.